Moonlake Immunotherapeutics (MLTX)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 19,751,284 | $932,260,605 | 33.31% | |
| 2. | Cormorant Asset Management Bihua Chen | 8,494,151 | $400,923,927 | 29.86% | |
| 3. | VenBio Select Advisor Kurt Von Emster | 4,150,000 | $195,880,000 | +50% | 3.43% |
| 4. | Citadel Investment Group Ken Griffin | 1,674,041 | $79,014,736 | +14% | 0.01% |
| 5. | Hood River Capital Management David Swank | 675,445 | $31,881,004 | +2% | 0.45% |
Hedge Fund Resource Center Billionaire Hedge Funds
